Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies, The Journal of Lipid Research, vol.47, issue.8, pp.1620-1650, 2006. ,
DOI : 10.1194/jlr.R600013-JLR200
Differential effects of saturated fatty acids on low density lipoprotein metabolismnea pig, J Lipid research, vol.33, pp.1833-1875, 1992. ,
Beyond cholesterol. Modifications of lowdensity lipoprotein that increase its atherogenicity, N Engl J Med, vol.320, pp.915-939, 1989. ,
Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein., Proceedings of the National Academy of Sciences, vol.82, issue.17, pp.5949-53, 1985. ,
DOI : 10.1073/pnas.82.17.5949
Role of Oxidative Modifications in Atherosclerosis, Physiological Reviews, vol.84, issue.4, pp.1381-478, 2004. ,
DOI : 10.1152/physrev.00047.2003
Antioxidants and atherosclerotic heart disease, N Engl J Med, vol.337, pp.408-424, 1997. ,
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids., Proceedings of the National Academy of Sciences, vol.81, issue.12, pp.3883-3890, 1984. ,
DOI : 10.1073/pnas.81.12.3883
levels are elevated in individuals with non-insulin dependent diabetes mellitus, FEBS Letters, vol.23, issue.2, pp.225-234, 1995. ,
DOI : 10.1016/0014-5793(95)00649-T
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.10, pp.2175-83, 2000. ,
DOI : 10.1161/01.ATV.20.10.2175
Reactive oxygen species as mediators of angiotensin II signaling, Regulatory Peptides, vol.91, issue.1-3, pp.21-28, 2000. ,
DOI : 10.1016/S0167-0115(00)00136-1
-Isoprostanes) in Smokers ??? Smoking as a Cause of Oxidative Damage, New England Journal of Medicine, vol.332, issue.18, pp.1198-203, 1995. ,
DOI : 10.1056/NEJM199505043321804
URL : https://hal.archives-ouvertes.fr/in2p3-00024374
Points of control in inflammation, Nature, vol.17, issue.6917, pp.846-52, 2002. ,
DOI : 10.1073/pnas.94.20.10919
AHA guideline on the treatment of blood cholesterol to reduce atherosclerosic cardiovascular risk in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines, ACC Circulation, vol.10, pp.1161-1201, 2013. ,
The discovery and development of HMG-CoA reductase inhibitors, Atherosclerosis Supplements, vol.5, issue.3, pp.1569-82, 1992. ,
DOI : 10.1016/j.atherosclerosissup.2004.08.026
HMG-CoA reductase inhibitors for treatment of hypercholesterolemia, N. Engl. J. Med, vol.319, pp.24-33, 1988. ,
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170???000 participants in 26 randomised trials, The Lancet, vol.376, issue.9753, pp.1670-81, 2010. ,
DOI : 10.1016/S0140-6736(10)61350-5
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis, Cochrane Database Syst Rev, vol.336, issue.7645, p.7784, 2009. ,
DOI : 10.1002/14651858.CD007784
Clinical implications for statin pleiotropy, Current Opinion in Lipidology, vol.16, issue.6, pp.624-633, 2005. ,
DOI : 10.1097/01.mol.0000191913.16321.60
Les effets pléiotropes des statines ont-ils un interêt clinique ? Arch Mal Coeur Vaiss, pp.1231-1236, 2004. ,
An Assessment of Statin Safety by Muscle Experts, The American Journal of Cardiology, vol.97, issue.8, pp.69-76, 2006. ,
DOI : 10.1016/j.amjcard.2005.12.013
The safety of statins in clinical practice, The Lancet, vol.370, issue.9601, pp.1781-1790, 2007. ,
DOI : 10.1016/S0140-6736(07)60716-8
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials, The Lancet, vol.375, issue.9716, pp.735-777, 2010. ,
DOI : 10.1016/S0140-6736(09)61965-6
Statin therapy and risk of Developing Type 2 diabete: A meta-Analysis, Diabetes Care, vol.32, issue.10, pp.1924-1953, 2009. ,
atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, pitavastatin, rosuvastatin) and safety the risk of nowonset diabetes/impaired glucose metabolism Agreed by PhVWP, Heads of Medicines Agencies. Mars, 2012. ,
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial, The Lancet, vol.360, issue.9346, pp.1623-1632, 2002. ,
DOI : 10.1016/S0140-6736(02)11600-X
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein, New England Journal of Medicine, vol.359, issue.21, pp.2195-207, 2008. ,
DOI : 10.1056/NEJMoa0807646
Statins for Secondary Prevention in Elderly Patients, Journal of the American College of Cardiology, vol.51, issue.1, pp.37-45, 2008. ,
DOI : 10.1016/j.jacc.2007.06.063
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study, The Lancet, vol.358, issue.9279, pp.351-356, 2001. ,
DOI : 10.1016/S0140-6736(01)05553-2
Low serum total cholesterol concentrations and mortality in middle aged British men, BMJ, vol.311, issue.7002, pp.409-422, 1995. ,
DOI : 10.1136/bmj.311.7002.409
Traditional Risk Factors and Subclinical Disease Measures as Predictors of First Myocardial Infarction in Older Adults, Archives of Internal Medicine, vol.159, issue.12, pp.1339-1386, 1999. ,
DOI : 10.1001/archinte.159.12.1339
Relations between HDL-cholestérol and cardiovascular disease, Arch Mal Coeur Vaiss, vol.85, issue.3, pp.21-28, 1992. ,
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES, American Journal of Epidemiology, vol.110, issue.3, pp.281-90, 1979. ,
DOI : 10.1093/oxfordjournals.aje.a112813
Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men, Archives of Internal Medicine, vol.152, issue.1, pp.56-64, 1992. ,
DOI : 10.1001/archinte.1992.00400130082009
Total cholesterol and risk of mortality in the oldest old, The Lancet, vol.350, issue.9085, pp.1119-1142, 1997. ,
DOI : 10.1016/S0140-6736(97)04430-9
CHOLESTEROL AS RISK FACTOR FOR MORTALITY IN ELDERLY WOMEN, The Lancet, vol.333, issue.8643, pp.868-70, 1989. ,
DOI : 10.1016/S0140-6736(89)92865-1
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?, BMJ, vol.308, issue.6925, pp.367-72, 1994. ,
DOI : 10.1136/bmj.308.6925.367
Estimating the Benefits of Modifying Risk Factors of Cardiovascular Disease, Archives of Internal Medicine, vol.158, issue.6, pp.655-62, 1998. ,
DOI : 10.1001/archinte.158.6.655
The 'diet heart' hypothesis in secondary prevention of coronary heart disease, European Heart Journal, vol.18, issue.1, pp.13-21, 1997. ,
DOI : 10.1093/oxfordjournals.eurheartj.a015094
URL : https://hal.archives-ouvertes.fr/hal-00395471
Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study, BMJ, vol.338, issue.jun23 2, pp.2337-2338, 2009. ,
DOI : 10.1136/bmj.b2337
Effects of Exercise on Lipoprotein(a), Sports Medicine, vol.28, issue.1, pp.11-24, 1999. ,
DOI : 10.2165/00007256-199928010-00002
Médecine préventive chez les personnes agées: les effets préventifs de l'ativité physique chez les personnes agées, Presse Med, vol.29, pp.1240-1248, 2000. ,
Ageing, physical activity and mortality--a 42-year follow-up study, International Journal of Epidemiology, vol.41, issue.2 ,
DOI : 10.1093/ije/dyr205